Skip to content

Clinical trials

Phase 3 Coronary Disease trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Disease Phase: Phase 3 Country / region: Germany Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20083
20093
20111
20121
20131
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline2
University of Erlangen-Nürnberg Medical School2
Abbott Medical Devices1
Amgen1
Hoffmann-La Roche1
Johns Hopkins University1
Kastle Therapeutics, LLC1
Ludwig-Maximilians - University of Munich1
Martin-Luther-Universität Halle-Wittenberg1
RWTH Aachen University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Disease12
Atherosclerosis3
Heart Diseases3
Cardiovascular Diseases2
Coronary Artery Disease2
Hypercholesterolemia2
Myocardial Ischemia2
Vascular Diseases2
Acute Coronary Syndrome1
Arterial Occlusive Diseases1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.